O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
-15.63%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$5.36B
AUM Growth
+$5.36B
(-35%)
Cap. Flow
-$1.44B
Cap. Flow
% of AUM
-26.93%
Top 10 Holdings %
Top 10 Hldgs %
37.64%
Holding
161
New
13
Increased
16
Reduced
46
Closed
30
Top Buys
| 1 |
THOR
Synthorx, Inc. Common Stock
THOR
|
$92.4M |
| 2 |
LOGC
LogicBio Therapeutics, Inc. Common Stock
LOGC
|
$67.3M |
| 3 |
Guardant Health
GH
|
$57.7M |
| 4 |
CVS Health
CVS
|
$52M |
| 5 |
CELG
Celgene Corp
CELG
|
$50.8M |
Top Sells
| 1 |
Jazz Pharmaceuticals
JAZZ
|
$149M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$81.2M |
| 3 |
Edwards Lifesciences
EW
|
$80.4M |
| 4 |
Merck
MRK
|
$80.2M |
| 5 |
Bristol-Myers Squibb
BMY
|
$79M |
Sector Composition
| 1 | Healthcare | 96% |
| 2 | Financials | 0.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Bausch Health
BHC
$2.74B
| $66.5M | 1.23% | 3,600,300 +1,696,400 | +89% | +$31.3M |
|
27
argenx
ARGX
$43.6B
| $62.2M | 1.15% | 647,600 -71,200 | -10% | -$6.84M |
|
28
Humana
HUM
$36.5B
| $59.2M | 1.09% | 206,500 -186,500 | -47% | -$53.4M |
|
|
29
Guardant Health
GH
$8.41B
| $57.7M | 1.07% | +1,534,464 | New | +$57.7M |
|
30
Crinetics Pharmaceuticals
CRNX
$2.92B
| $57.4M | 1.06% | 1,914,282 | – | – |
|
31
Exelixis
EXEL
$10.1B
| $55.1M | 1.02% | 2,801,900 | – | – |
|
32
Puma Biotechnology
PBYI
$254M
| $52.9M | 0.98% | 2,598,883 -106,298 | -4% | -$2.16M |
|
33
PTC Therapeutics
PTCT
$3.92B
| $52.2M | 0.96% | 1,519,700 +244,700 | +19% | +$8.4M |
|
|
34
CVS Health
CVS
$92.8B
| $52M | 0.96% | +793,800 | New | +$52M |
|
|
DCPH
35
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $51.3M | 0.95% | 2,442,200 +488,700 | +25% | +$10.3M |
|
36
Agilent Technologies
A
$35.7B
| $50.8M | 0.94% | 753,000 -332,100 | -31% | -$22.4M |
|
|
CLVS
37
DELISTED
Clovis Oncology, Inc.
CLVS
| $49.4M | 0.91% | 2,752,200 +517,630 | +23% | +$9.3M |
|
38
Iovance Biotherapeutics
IOVA
$807M
| $49.1M | 0.91% | 5,548,326 | – | – |
|
39
Centene
CNC
$14.3B
| $48.1M | 0.89% | 417,400 +80,000 | +24% | +$9.22M |
|
40
UnitedHealth
UNH
$281B
| $46.5M | 0.86% | 186,500 | – | – |
|
41
eHealth
EHTH
$118M
| $42.3M | 0.78% | 1,100,000 -511,200 | -32% | -$19.6M |
|
42
Adicet Bio
ACET
$59.9M
| $41.6M | 0.77% | 4,830,387 | – | – |
|
43
Zai Lab
ZLAB
$3.68B
| $40.7M | 0.75% | 1,753,538 | – | – |
|
|
BOLD
44
DELISTED
Audentes Therapeutics, Inc
BOLD
| $40.4M | 0.75% | 1,893,500 -286,500 | -13% | -$6.11M |
|
|
ONC
45
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $39.6M | 0.73% | 282,500 | – | – |
|
|
BLUE
46
DELISTED
bluebird bio
BLUE
| $38.4M | 0.71% | 387,200 -72,000 | -16% | -$7.14M |
|
47
Heron Therapeutics
HRTX
$207M
| $36.3M | 0.67% | 1,400,300 -114,200 | -8% | -$2.96M |
|
48
Tandem Diabetes Care
TNDM
$845M
| $36M | 0.67% | 948,000 +233,500 | +33% | +$8.87M |
|
49
Molina Healthcare
MOH
$9.8B
| $35.4M | 0.66% | 305,000 -183,781 | -38% | -$21.4M |
|
50
Neurocrine Biosciences
NBIX
$13.8B
| $35.3M | 0.65% | 494,200 +356,400 | +259% | +$25.5M |
|